UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 138

Sortiert nach

An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients

European journal of cancer (1990), 2010-04, Vol.46 (6), p.1033-1040

2010

Volltextzugriff (PDF)

Decision-making in the end-of-life phase of high-grade glioma patients

European journal of cancer (1990), 2012-01, Vol.48 (2), p.226-232

2012

Volltextzugriff (PDF)

An Online Calculator for the Prediction of Survival in Glioblastoma Patients Using Classical Statistics and Machine Learning

Neurosurgery, 2020-02, Vol.86 (2), p.E184-E192

2020

Volltextzugriff (PDF)

Treatment of cognitive deficits in brain tumour patients: current status and future directions

Current opinion in oncology, 2019-11, Vol.31 (6), p.540

2019

Volltextzugriff (PDF)

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

Journal of clinical oncology, 2013-01, Vol.31 (3), p.344-350

2013

Volltextzugriff (PDF)

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

Journal of clinical oncology, 2009-03, Vol.27 (8), p.1268-1274

2009

Volltextzugriff (PDF)

Cognitive Rehabilitation in Patients With Gliomas: A Randomized, Controlled Trial

Journal of clinical oncology, 2009-08, Vol.27 (22), p.3712-3722

2009

Volltextzugriff (PDF)

The association between cognitive functioning and health-related quality of life in low-grade glioma patients

Neuro-oncology practice, 2014-06, Vol.1 (2), p.40-46

2014

Volltextzugriff (PDF)

Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study

Journal of neuro-oncology, 2023-09, Vol.164 (3), p.545-555

2023

Volltextzugriff (PDF)

International patterns of palliative care in neuro-oncology: a survey of physician members of the Asian Society for Neuro-Oncology, the European Association of Neuro-Oncology, and the Society for Neuro-Oncology

Neuro-oncology practice, 2015-06, Vol.2 (2), p.62-69

2015

Volltextzugriff (PDF)

MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951

Journal of clinical oncology, 2009-12, Vol.27 (35), p.5881-5886

2009

Volltextzugriff (PDF)

Evaluating the lack of impact of the e-health application Oncokompas on outcomes in incurably ill cancer patients

The Lancet regional health. Europe, 2022-07, Vol.18, p.100396-100396, Article 100396

2022

Volltextzugriff (PDF)

New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951

European journal of cancer (1990), 2013-11, Vol.49 (16), p.3477-3485

2013

Volltextzugriff (PDF)

A qualitative study on the healthcare experiences of adolescents and young adults (AYA) with an uncertain or poor cancer prognosis

Supportive care in cancer, 2023-12, Vol.31 (12), p.721-721, Article 721

2023

Volltextzugriff (PDF)

Health-Related Quality of Life or Quantity of Life: A Difficult Trade-Off in Primary Brain Tumors?

Seminars in oncology, 2014-08, Vol.41 (4), p.541-552

2014

Volltextzugriff (PDF)

Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study

Neurology, 2019-06, Vol.92 (24), p.e2754

2019

Volltextzugriff (PDF)

Evaluation of the Hippocampal Normal Tissue Complication Model in a Prospective Cohort of Low Grade Glioma Patients-An Analysis Within the EORTC 22033 Clinical Trial

Frontiers in oncology, 2019-10, Vol.9, p.991-991

2019

Volltextzugriff (PDF)

Predictors of subjective versus objective cognitive functioning in patients with stable grades II and III glioma

Neuro-oncology practice, 2015-03, Vol.2 (1), p.20-31

2015

Volltextzugriff (PDF)

Neurocognitive sequelae in the treatment of low-grade gliomas

Seminars in oncology, 2003-12, Vol.30 (6), p.45-48

Taphoorn, Martin J.B

2003

Volltextzugriff (PDF)

Advances in the management of glioblastoma

Journal of neurology, neurosurgery and psychiatry, 2021-10, Vol.92 (10), p.1103

2021

Volltextzugriff (PDF)

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

Nature reviews. Clinical oncology, 2021-03, Vol.18 (3), p.170-186

2021

Volltextzugriff (PDF)

Prevalence of changes in personality and behavior in adult glioma patients: a systematic review

Neuro-oncology practice, 2016-12, Vol.3 (4), p.222-231

2016

Volltextzugriff (PDF)

Health-related quality of life and other clinical outcome assessments in brain tumor patients: challenges in the design, conduct and interpretation of clinical trials

Neuro-oncology practice, 2015-03, Vol.2 (1), p.2-5

2015

Volltextzugriff (PDF)

1 – 25 von 138

Suche als RSS-Feed

Aktive Filter

ThemaQuality Of Life

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(123)

Publikationsform

Sprache

Englisch
(138)
Japanisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients

Decision-making in the end-of-life phase of high-grade glioma patients

An Online Calculator for the Prediction of Survival in Glioblastoma Patients Using Classical Statistics and Machine Learning

Treatment of cognitive deficits in brain tumour patients: current status and future directions

Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951

Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034

Cognitive Rehabilitation in Patients With Gliomas: A Randomized, Controlled Trial

The association between cognitive functioning and health-related quality of life in low-grade glioma patients

Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial

Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study

International patterns of palliative care in neuro-oncology: a survey of physician members of the Asian Society for Neuro-Oncology, the European Association of Neuro-Oncology, and the Society for Neuro-Oncology

MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951

Evaluating the lack of impact of the e-health application Oncokompas on outcomes in incurably ill cancer patients

New clinical, pathological and molecular prognostic models and calculators in patients with locally diagnosed anaplastic oligodendroglioma or oligoastrocytoma. A prognostic factor analysis of European Organisation for Research and Treatment of Cancer Brain Tumour Group Study 26951

A qualitative study on the healthcare experiences of adolescents and young adults (AYA) with an uncertain or poor cancer prognosis

Health-Related Quality of Life or Quantity of Life: A Difficult Trade-Off in Primary Brain Tumors?

Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study

Evaluation of the Hippocampal Normal Tissue Complication Model in a Prospective Cohort of Low Grade Glioma Patients-An Analysis Within the EORTC 22033 Clinical Trial

Predictors of subjective versus objective cognitive functioning in patients with stable grades II and III glioma

Neurocognitive sequelae in the treatment of low-grade gliomas

Advances in the management of glioblastoma

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

Prevalence of changes in personality and behavior in adult glioma patients: a systematic review

Health-related quality of life and other clinical outcome assessments in brain tumor patients: challenges in the design, conduct and interpretation of clinical trials

European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas

Aktive Filter

Suchergebnisse filtern